Current Neuro-Oncology

Volume 23 Number 7
15 April 2021

Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 7, 15 April

*

Dissaux G, Dissaux B, Bourhis D, Schick U, Querellou S.
18F-FET PET/CT in Early Subventricular Zone Recurrence of Adult Glioblastoma.
Clin Nucl Med. 2021 Apr 1∟. doi: 10.1097/RLU.0000000000003639∟. PMID: 33795588∟. Case report˰ ˍ

Filizoglu N, Oksuzoglu K, Ozguven S.
Distinguishing Meningioma From Metastasis of Prostate Cancer on ⁶⁸Ga-PSMA PET/CT.
Clin Nucl Med. 2021 Apr 1, 2021;46(11):e553-e555∟. doi: 10.1097/RLU.0000000000003629∟. PMID: 34606488∟. Case report˰ ˍ

Liu S, Liu Y, Li G, Feng J, Chen L, Qiu X.
High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma.
Chin Neurosurg J. 2021 Apr 1, 2021;7(1):22∟. doi: 10.1186/s41016-021-00239-z∟. PMID: 33795023∟. Observational study. ˍ

Tomei S, Volontè A, Ravindran S, Mazzoleni S, Wang E, Galli R, Maccalli C.
MicroRNA Expression Profile Distinguishes Glioblastoma Stem Cells from Differentiated Tumor Cells.
J Pers Med. 2021 Apr 1, 2021;11(4):264∟. doi: 10.3390/jpm11040264∟ PMID: 33916317∟. Laboratory investigation. ˍ

Cai JW, Chen XY, Chen JY, Wu ZY, Wu XY, Yu LH, You HH.
Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and TERT promoter mutations: A case report.
Medicine (Baltimore). 2021 Apr 2, 2021;100(13):e25346∟. doi: 10.1097/MD.0000000000025346∟. PMID: 33787635∟. Case report. ˍ

Rahman A, Lozada-Martinez ID, Rahman S, Ataullah AHM, Muñoz-Baez K, Moscote-Salazar LR, Agrawal A, Rahman MM.
Letter: A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.
Neurosurgery. 2021 Apr 2, 2021:nyab097∟. doi: 10.1093/neuros/nyab097∟. PMID: 33822209∟. Comment. ˍ
Refers to: Peereboom DM, et al., A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.
Neurosurgery. 2020 Oct 7, 2021;88(2):246-251∟. doi: 10.1093/neuros/nyaa412∟. PMID: 33027815∟. Interventional study. ˍ ˍ

Jazmati D, Steinmeier T, Ahamd Khalil D, Frisch S, Peters S, Schulze Schleithoff S, Bäumer C, Rutkowski S, Frühwald MC, Blase C, Tippelt S, Timmermann B.
Feasibility of Proton Beam Therapy for Infants with Brain Tumours: Experiences from the Prospective KiProReg Registry Study.
Clin Oncol (R Coll Radiol). 2021 Apr 3, 2021;33(7):e295-e304∟. doi: 10.1016/j.clon.2021.03.006∟. PMID: 33820696∟. Observational study. ˍ

Zheng L, Zhou ZR, Shi M, Chen H, Yu QQ, Yang Y, Liu L, Zhang L, Guo Y, Zhou X, Li C, Wei Q.
Nomograms for predicting progression-free survival and overall survival after surgery and concurrent chemoradiotherapy for glioblastoma: a retrospective cohort study.
Ann Transl Med. 2021 Apr 4, 2021;9(7):571∟. doi: 10.21037/atm-21-673∟. PMID: 33987269∟. Observational study. ˍ

Casale R, Lavrova E, Sanduleanu S, Woodruff HC, Lambin P.
Development and external validation of a non-invasive molecular status predictor of chromosome 1p/19q co-deletion based on MRI radiomics analysis of Low Grade Glioma patients.
Eur J Radiol. 2021 Apr 5, 2021;139:109678∟. doi: 10.1016/j.ejrad.2021.109678∟. PMID: 33848780∟. Observational study. ˍ

Kertels O, Breun M, Hänscheid H, Kircher M, Hartrampf PE, Schirbel A, Monoranu CM, Ernestus RI, Buck AK, Löhr M, Matthies C, Lapa C.
Peptide Receptor Radionuclide Therapy in Patients With Neurofibromatosis Type 2: Initial Experience.
Clin Nucl Med. 2021 Apr 5∟. doi: 10.1097/RLU.0000000000003627∟. PMID: 33826573∟. Observational study˰ ˍ

Yu Y, Villanueva-Meyer J, Grimmer MR, Hilz S, Solomon DA, Choi S, Wahl M, Mazor T, Hong C, Shai A, Phillips JJ, Wainer BH, McDermott M, Haas-Kogan D, Taylor JW, Butowski N, Clarke JL, Berger MS, Molinaro AM, Chang SM, Costello JF, Oberheim Bush NA.
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.
Neuro Oncol. 2021 Apr 5, 2021:noab081∟. doi: 10.1093/neuonc/noab081∟. PMID: 33823014∟. Observational study. ˍ

Frappaz D, Barritault M, Montané L, Laigle-Donadey F, Chinot O, Le Rhun E, Bonneville-Levard A, Hottinger AF, Meyronnet D, Bidaux AS, Garin G, Pérol D.
MEVITEM - A Phase I/II of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.
Neuro Oncol. 2021 Apr 7, 2021:noab087∟. doi: 10.1093/neuonc/noab087∟. PMID: 33825892∟. Interventional study. ˍ

Lietke S, Schmutzer M, Schwartz C, Weller J, Siller S, Aumiller M, Heckl C, Forbrig R, Niyazi M, Egensperger R, Stepp H, Sroka R, Tonn JC, Rühm A, Thon N.
Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences.
Cancers (Basel). 2021 Apr 7, 2021;13(8):1767∟. doi: 10.3390/cancers13081767∟. PMID: 33917116∟. Observational study. ˍ

Müller DMJ, De Swart ME, Ardon H, Barkhof F, Bello L, Berger MS, Bouwknegt W, Van den Brink WA, Conti Nibali M, Eijgelaar RS, Furtner J, Han SJ, Hervey-Jumper S, Idema AJS, Kiesel B, Kloet A, Mandonnet E, Robe PAJT, Rossi M, Sciortino T, Vandertop WP, Visser M, Wagemakers M, Widhalm G, Witte MG, De Witt Hamer PC.
Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study.
Neurooncol Adv. 2021 Apr 8, 2021;3(1):vdab053∟. doi: 10.1093/noajnl/vdab053∟. PMID: 34056605∟. Observational study. ˍ

Bernchou U, Skak Tranemose Arnold T, Axelsen B, Klüver-Kristensen M, Mahmood F, Severin Gråe Harbo F, Thor Asmussen J, Hansen O, Smedegaard Bertelsen A, Hansen S, Brink C, Hedegaard Dahlrot R.
Evolution of the gross tumour volume extent during radiotherapy for glioblastomas.
Radiother Oncol. 2021 Apr 9, 2021;160:40-46∟. doi: 10.1016/j.radonc.2021.04.001∟. PMID: 33848564∟. Interventional study. ˍ

Bobeff K, Krajewska K, Baranska D, Kotulska K, Jozwiak S, Mlynarski W, Trelinska J.
Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis - Final Results From the EMINENTS Study.
Front Neurol. 2021 Apr 9, 2021;12:581102∟. doi:10.3389/fneur.2021.581102∟. PMID: 33897576∟. Interventional study. ˍ

On J, Natsumeda M, Watanabe J, Saito S, Kanemaru Y, Abe H, Tsukamoto Y, Okada M, Oishi M, Yoshimura J, Kakita A, Fujii Y.
Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas.
Diagnostics (Basel). 2021 Apr 9, 2021;11(4):681∟. doi: 10.3390/diagnostics11040681∟. PMID: 33918936∟. Observational study. ˍ

Pasquini L, Napolitano A, Tagliente E, Dellepiane F, Lucignani M, Vidiri A, Ranazzi G, Stoppacciaro A, Moltoni G, Nicolai M, Romano A, Di Napoli A, Bozzao A.
Deep Learning Can Differentiate IDH-Mutant from IDH-Wild GBM.
J Pers Med. 2021 Apr 9, 2021;11(4):290∟. doi: 10.3390/jpm11040290∟. PMID: 33918828∟. Observational study. ˍ

Sinai Khandeparkar SG, Gosavi SS, Gogate BP, Talathi N.
A rare case of cerebellar pilomyxoid astrocytoma associated with neurofibromatosis-1 in a young female; case report highlighting immunohistochemical features.
Indian J Pathol Microbiol. 2021 Apr 9, 2021;64(2):354-357∟. doi: 10.4103/IJPM.IJPM_209_20(?). PMID: 33851634∟. Case report. ˍ

Zhao M, Fu X, Zhang Z, Li A, Wang X, Li X.
Intracranial 131I-chTNT Brachytherapy in Patients with Deep-Seated Glioma: A Single-center Experience with 10-Year Follow-up from China.
Nuklearmedizin. 2021 Apr 9∟. doi: 10.1055/a-1429-1967∟. PMID: 33836553∟. Observational study˰ ˍ

Friedman GK, Johnston JM, Bag AK, Bernstock JD, Li R, Aban I, Kachurak K, Nan L, Kang KD, Totsch S, Schlappi C, Martin AM, Pastakia D, McNall-Knapp R, Farouk Sait S, Khakoo Y, Karajannis MA, Woodling K, Palmer JD, Osorio DS, Leonard J, Abdelbaki MS, Madan-Swain A, Atkinson TP, Whitley RJ, Fiveash JB, Markert JM, Gillespie GY.
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.
N Engl J Med. 2021 Apr 10∟. doi: 10.1056/NEJMoa2024947∟. PMID: 33838625∟. Interventional study. ˍ

Hong S, Sato K, Kagawa K, Ichi S.
The long-term outcome of CyberKnife-based stereotactic radiotherapy for central skull base meningiomas: a single-center experience.
Neurosurg Rev. 2021 Apr 10∟. doi: 10.1007/s10143-021-01535-z∟. PMID: 33839946∟. Observational study. ˍ

*

Levy AS, Krailo M, Chi S, Villaluna D, Springer L, Williams-Hughes C, Fouladi M, Gajjar A.
Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial.
Pediatr Blood Cancer. 2021 Apr 12, 2021:e29031∟. doi: 10.1002/pbc.29031∟. PMID: 33844469∟. Interventional study. ˍ

Baldovin M, Saratziotis A, Munari S, Emanuelli E.
Diagnosis and treatment of congenital nasal glioma.
BMJ Case Rep. 2021 Apr 13, 2021;14(4):e242138∟. doi: 10.1136/bcr-2021-242138∟. PMID: 33849883∟. Case report. ˍ

Sato H, Mizumoto M, Okumura T, Sakurai H, Sakamoto N, Akutsu H, Ishikawa E, Tsuboi K.
Long-term outcomes of patients with unresectable benign meningioma treated with proton beam therapy.
J Radiat Res. 2021 Apr 13, 2021:rrab017∟. doi: 10.1093/jrr/rrab017∟. PMID: 33855438∟. Observational study. ˍ

Wang Y, Xu J, Luo N, Qi C, Tao R.
Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab.
Invest New Drugs. 2021 Apr 13∟. doi: 10.1007/s10637-021-01116-3∟. PMID: 33851364∟. Case report. ˍ

Pan SP, Zheng XL, Zhang N, Lin XM, Li KJ, Xia XF, Zou CL, Zhang WY.
A novel nomogram for predicting the risk of epilepsy occurrence after operative in gliomas patients without preoperative epilepsy history.
Epilepsy Res. 2021 Apr 14, 2021;174:106641∟. doi: 10.1016/j.eplepsyres.2021.106641∟. PMID: 33878595∟. Observational study. ˍ

Gangoso E, Southgate B, Bradley L, Rus S, Galvez-Cancino F, McGivern N, Güç E, Kapourani CA, Byron A, Ferguson KM, Alfazema N, Morrison G, Grant V, Blin C, Sou I, Marques-Torrejon MA, Conde L, Parrinello S, Herrero J, Beck S, Brandner S, Brennan PM, Bertone P, Pollard JW, Quezada SA, Sproul D, Frame MC, Serrels A, Pollard SM.
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion.
Cell. 2021 2021 Apr 14, 2021;184(9):2454-2470.e26∟. doi: 10.1016/j.cell.2021.03.023∟. PMID: 33857425∟. Laboratory investigation. ˍ

Goel A, Vutha R, Shah A, Singh K, Goel N, Shenoy A, Rai S, Dandpat S.
Large lateral intraventricular tumors - Outcome of radical surgery.
J Clin Neurosci. 2021 Apr 14, 2021;88:205-212∟. doi: 10.1016/j.jocn.2021.03.040∟. PMID: 33992185∟. Observational study. ˍ

Vils A, Bogowicz M, Tanadini-Lang S, Vuong D, Saltybaeva N, Kraft J, Wirsching HG, Gramatzki D, Wick W, Rushing E, Reifenberger G, Guckenberger M, Weller M, Andratschke N.
Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial.
Front Oncol. 2021 Apr 14, 2021;11:636672∟. doi: 10.3389/fonc.2021.636672∟. PMID: 33937035∟. Observational study. ˍ

Zhang Y, Kim J, Andrews C, Archer E, Bursztyn L, Grabe H, Margolin E, Sullivan S, Trobe J.
Visual Outcomes in Surgically Treated Intracranial Meningiomas.
J Neuroophthalmol. 2021 Apr 14∟. doi: 10.1097/WNO.0000000000001205∟. PMID: 33870941∟. Observational study˰ ˍ

Królicki L, Bruchertseifer F, Kunikowska J, Koziara H, Pawlak D, Kuliński R, Rola R, Merlo A, Morgenstern A.
Dose escalation study of targeted alpha therapy with [²²⁵Ac]Ac-DOTA-substance P in recurrence glioblastoma – safety and efficacy.
Eur J Nucl Med Mol Imaging. 2021 Apr 15∟. doi: 10.1007/s00259-021-05350-y∟. PMID: 33860346∟. Interventional study. ˍ

Talati P, El-Abtah M, Kim D, Dietrich J, Fu M, Wenke M, He J, Natheir SN, Vangel M, Rapalino O, Vaynrub A, Arrillaga-Romany I, Forst DA, Yen YF, Andronesi O, Kalpathy-Cramer J, Rosen B, Batchelor TT, Gonzalez RG, Gerstner ER, Ratai EM.
MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma.
Neurooncol Adv. 2021 Apr 15, 2021;3(1):vdab060∟. doi: 10.1093/noajnl/vdab060∟. PMID: 34131648∟. Observational study.ˍ